K-<i>ras</i>Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
Robert J.C. Slebos(The Netherlands Cancer Institute), Sjoerd Rodenhuis(The Netherlands Cancer Institute), Otilia Dalesio(The Netherlands Cancer Institute), R.E. Kibbelaar(The Netherlands Cancer Institute), Chris J.L.M. Meijer(Dutch Cancer Society), Nico van Zandwijk(Unknown), Jacob Stam, Wolter J. Mooi(The Netherlands Cancer Institute), Sjoerd Sc. Wagenaar(University of Amsterdam), R.G.J.R.A. Vanderschueren(University of Amsterdam), A. Kooistra, Johannes L. Bos(University Medical Center Utrecht)
Cited by 811
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k
Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners
|New England Journal of Medicine|2002|806
Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy
|JNCI Journal of the National Cancer Institute|1998|768